Accelerated drug development timelines must accommodate all crucial elements of nonclinical safety studies.
Shannon Parisotto
Advertisement
Shannon Parisotto, MBA, is the corporate senior vice president of Charles River Laboratories.
Articles by Shannon Parisotto
Advertisement
Latest Updated Articles
Advertisement
Advertisement
